作用機序 - 暇つぶしWikipedia

作用機序

□記事を途中から表示しています
[最初から表示]

脚注[脚注の使い方]^ Ogrodowczyk, M.; Dettlaff, K.; Jelinska, A. (2016). “Beta-blockers: Current state of knowledge and perspectives”. Mini Reviews in Medicinal Chemistry 16 (1): 40?54. doi:10.2174/1389557515666151016125948. .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation.cs-ja1 q,.mw-parser-output .citation.cs-ja2 q{quotes:"「""」""『""』"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}PMID 26471965.
^ a b Spratto, G.R.; Woods, A.L. (2010). Delmar Nurse's Drug Handbook. Cengage Learning. ISBN 978-1-4390-5616-5
^ Grant, R.L.; Combs, A.B.; Acosta, D. (2010) "Experimental Models for the Investigation of Toxicological Mechanisms". In McQueen, C.A. Comprehensive Toxicology (2nd ed.). Oxford: Elsevier. p. 204. ISBN 978-0-08-046884-6.
^ a b c d e Cushnie, T.P.; O’Driscoll, N.H.; Lamb, A.J. (2016). “Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action”. Cellular and Molecular Life Sciences 73 (23): 4471?4492. doi:10.1007/s00018-016-2302-2. hdl:10059/2129. PMID 27392605. https://zenodo.org/record/883501.
^ Chang, C.C.; Slavin, M.A.; Chen, S.C. (2017). “New developments and directions in the clinical application of the echinocandins”. Archives of Toxicology 91 (4): 1613?1621. doi:10.1007/s00204-016-1916-3. PMID 28180946.
^ a b No authors listed (2010). “Mechanism matters”. Nature Medicine 16 (4): 347. doi:10.1038/nm0410-347. PMID 20376007.
^ Joensuu, H. (2017). “Escalating and de-escalating treatment in HER2-positive early breast cancer”. Cancer Treatment Reviews 52: 1?11. doi:10.1016/j.ctrv.2016.11.002. PMID 27866067. https://helda.helsinki.fi/handle/10138/176779.
^ Cihlar, T.; Fordyce, M. (2016). “Current status and prospects of HIV treatment”. Current Opinion in Virology 18: 50?56. doi:10.1016/j.coviro.2016.03.004. PMID 27023283.
^ Antony, H.A.; Parija, S.C. (2016). “Antimalarial drug resistance: An overview”. Tropical Parasitology 6 (1): 30?41. doi:10.4103/2229-5070.175081. PMC 4778180. PMID 26998432. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778180/.
^ Bozic, I.; Reiter, J.G.; Allen, B.; Antal, T.; Chatterjee, K.; Shah, P.; Moon, Y.S.; Yaqubie, A.; Kelly, N.; Le, D.T.; Lipson, E.J.; Chapman, P.B.; Diaz, L.A.; Vogelstein, B., Nowak, M.A. (2013). “Evolutionary dynamics of cancer in response to targeted combination therapy”. eLife 2: Article ID e00747. doi:10.7554/eLife.00747. PMC 3691570. PMID 23805382. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691570/.

次ページ

記事の検索

Size:36 KB
出典: フリー百科事典『ウィキペディア（Wikipedia）』
担当:undef